Key Takeaways
- • Dental Boutique's founders are exploring a sale of a significant stake in the dental chain through Morgan Stanley, targeting a valuation exceeding $500 million.
- • The business is projected to generate $40 million in EBITDA in the next financial year, up from $35 million, supporting the valuation multiple implicit in the asking price.
- • Founders Dr. Reuben Sim and Dr. May Chan built Dental Boutique from a single Melbourne clinic in 2013 to a 16-clinic national chain, positioning it as an attractive consolidation target.
- • Morgan Stanley began outreach to potential private equity bidders this week, indicating an active sell-side process is now underway.
- • The transaction represents activity in the broader dental services consolidation trend, where private equity has been increasingly active in acquiring and scaling dental practice groups.
Summary
Dental Boutique, an Australian dental services operator founded by Dr. Reuben Sim and Dr. May Chan in 2013, has launched a formal sale process with investment bank Morgan Stanley advising on the transaction. The founders are seeking a growth-minded private equity partner and have established a valuation floor of $500 million-plus for a significant stake in the business.
Morgan Stanley initiated outreach to potential bidders this week with financial projections showing Dental Boutique expects to deliver $40 million in EBITDA in the next financial year, representing growth from $35 million in the current period. This earnings trajectory underpins the asking valuation and suggests the founders view the business as capable of supporting mid-to-high single-digit EBITDA multiples typical in dental services consolidation transactions.
Built organically from a single clinic in Melbourne to a 16-clinic network, Dental Boutique has developed operational scale and geographic reach that appeals to acquisition-minded sponsors. The business represents a consolidation play within the broader dental services organization (DSO) market, where private equity has maintained significant investment appetite despite broader market normalization in recent years.
The formal engagement of a bulge-bracket investment banker and the specified financial metrics suggest this is a structured, competitive process rather than exploratory discussions. The outcome will depend on bidder conviction around growth prospects, integration synergies, and the founders' expectations regarding retained equity stakes and ongoing involvement post-transaction.
Morgan Stanley initiated outreach to potential bidders this week with financial projections showing Dental Boutique expects to deliver $40 million in EBITDA in the next financial year, representing growth from $35 million in the current period. This earnings trajectory underpins the asking valuation and suggests the founders view the business as capable of supporting mid-to-high single-digit EBITDA multiples typical in dental services consolidation transactions.
Built organically from a single clinic in Melbourne to a 16-clinic network, Dental Boutique has developed operational scale and geographic reach that appeals to acquisition-minded sponsors. The business represents a consolidation play within the broader dental services organization (DSO) market, where private equity has maintained significant investment appetite despite broader market normalization in recent years.
The formal engagement of a bulge-bracket investment banker and the specified financial metrics suggest this is a structured, competitive process rather than exploratory discussions. The outcome will depend on bidder conviction around growth prospects, integration synergies, and the founders' expectations regarding retained equity stakes and ongoing involvement post-transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.